Aggressive NK-cell leukemia shares some clinicopathological features with systemic EBV-positive T-cell lymphoma of childhood, but the immunophenotype of the neoplastic cells is basically different between these two disease entities (CD56+ NK cells vs. CD56- T cells). This evidence concerns the gene NCAM1 and aggressive NK-cell leukemia.